A Trial to Testify the Safety of Vaccinal Myxoma Virus on Spermatogenesis in Rabbits

Authors

  • Iliyan Manev University of Forestry, Faculty of Veterinary Medicine, Sofia
  • Krasimira Genova University of Forestry, Faculty of Veterinary Medicine, Sofia
  • Dessislava Gradinarska Institute of biology and immunology of reproduction, BAS
  • Krasimir Velikov Institude for husbandry sciences, Kostinbrod

Keywords:

myxoma virus, rabbit, vaccination, spermatogenesis, CASA

Abstract

The aim of our study was to monitor in dynamics the impact and safety of attenuated vaccinal myxoma virus strain on some rabbit semen characteristics. Male rabbits of New Zealand White line were vaccinated (on D0) with attenuated myxomatosis vaccine with standard dose (group A, n=10) and compared in dynamic to control unvaccinated animals (group B, n=6). The samples were collected using an artificial vagina twice – on D20 and D50 post vaccination. Semen samples were analyzed using CASA system in order to evaluate the concentration, motility and velocity parameters of rabbit spermatozoa. Our study showed that there is no negative influence in basic spermatogenic parameters and the quality of rabbits’ semen is not negatively affected by standard myxomatosis vaccination.

Downloads

Published

2016-07-14

How to Cite

Manev, I., Genova, K., Gradinarska, D., & Velikov, K. (2016). A Trial to Testify the Safety of Vaccinal Myxoma Virus on Spermatogenesis in Rabbits. TRADITION AND MODERNITY IN VETERINARY MEDICINE, 1(1), 61–65. Retrieved from https://www.scij-tmvm.com/index.php/pub/article/view/5

Issue

Vol. 1 No. 1 (2016): Volume 1 Issue 1 (2016)

Section

Articles

License

Copyright (c) 2016 TRADITION AND MODERNITY IN VETERINARY MEDICINE

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.